Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (23)

2024

  1. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

2023

  1. Genetic testing in focal segmental glomerulosclerosis: in whom and when?

    Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2011-2022

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

2021

  1. Hemodialysis Centers Guide 2020

    Nefrologia, Vol. 41, pp. 1-77

2020

  1. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

2017

  1. Testosterone deficiency in dialysis patients: Difference between dialysis techniques

    Nefrologia, Vol. 37, Núm. 5, pp. 526-530

2014

  1. Fallo precoz de trasplante renal y vuelta a diálisis peritoneal: Estudio preliminar de permeabilidad y eficacia de diálisis

    Nefrologia, Vol. 34, Núm. 1, pp. 105-109

  2. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

  3. Influencia de las soluciones glucosadas en el desarrollo de hiperglucemia en diálisis peritoneal. Comportamiento de la hemoglobina glucosilada y el perfil lipídico

    Nefrologia

2013

  1. Activación de los receptores de vitamina Den la optimización del hiperparatiroidismo secundario en diálisis

    Nefrologia, Vol. 33, Núm. 4, pp. 571-584

  2. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease

    Journal of Renal Nutrition, Vol. 23, Núm. 5

2012

  1. Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol - a preliminary study

    Clinical Nephrology, Vol. 78, Núm. 2, pp. 93-99

2011

  1. Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 27, pp. 130-133

2010

  1. Plan de calidad científico-técnica y de mejora continua de calidad en diálisis peritoneal

    Nefrologia, Vol. 30, Núm. 1, pp. 28-45

  2. Ver comentario editorial en página 599 Morbimortalidad en pacientes diabéticos en diálisis peritoneal. Experiencia de 25 años en un solo centro

    Nefrologia, Vol. 30, Núm. 6, pp. 626-632

2009

  1. Early initiation of peritoneal dialysis in diabetic patients

    Scandinavian Journal of Urology and Nephrology, Vol. 43, Núm. 2, pp. 148-153

  2. Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 25, pp. 115-118

2008

  1. Irbesartan y enfermedad renal crónica avanzada de causa no diabética. Estudio comparativo con IECAS

    Nefrologia, Vol. 28, Núm. 1, pp. 56-60

2007

  1. Impacts of cardiovascular events on residual renal function during the first year of peritoneal dialysis

    Peritoneal Dialysis International, Vol. 27, Núm. 4, pp. 454-456

  2. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 23, pp. 140-143